AXIM Biotechnologies Inc (AXIM) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
AXIM Biotechnologies settled a legal dispute with Innovative Medical Supplies involving allegations of fraud and other causes of action by entering into a confidential agreement to avoid the costs and uncertainty of litigation. Although denying any wrongdoing, AXIM will pay $100,000 over 24 months, participate in cassette sales, and issue 20 million restricted shares to settle all claims. This comprehensive settlement aims to put an end to both the ongoing lawsuit and any related future claims.
For further insights into AXIM stock, check out TipRanks’ Stock Analysis page.